Search

everythinglearnresearchcommunity

for

Search:↓

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Platelet-rich plasma may help in skin and hair treatments, and with muscle and joint healing, but more research is needed to fully understand its benefits and limitations.

Zinc deficiency in children can cause skin issues and can be serious if not diagnosed and treated properly.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Air pollution (PM10) increases skin inflammation and aging by reducing collagen and may trigger a repair response in skin cells.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Cats with atopic dermatitis often have severe, year-round itching and respond well to certain treatments.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Dupilumab for eczema may cause hair loss.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Hydrogen peroxide can cause scars by changing healing processes and increasing certain protein levels.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Safflower (Carthamus tinctorius) extract helps hair grow and could be used in hair products.

Hair microRNAs could be effective biomarkers for diagnosing scleroderma.

Apigenin may help promote hair growth and could treat hair loss.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Toxic shock syndrome is caused by a complex interaction of bacterial toxins and the immune system, and understanding this can help improve diagnosis and treatment.

Geranium sibiricum extract helps hair grow and is more effective than minoxidil but can be toxic in high concentrations.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.